CYTK News Alert Cytokinetics Inc (CYTK) 8.01 01/01/2015 15:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cytokinetics Inc (CYTK) 8.01 $CYTK

Nasdaq stocks posting largest percentage increases
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
RESN: 11.62 (+1.30), CYTK: 8.01 (+1.11), SIGM: 7.40 (+0.99), SIBC: 20.72 (+5.36), IDSA: 5.97 (+1.09), OCRX: 6.37 (+0.68), DJCO: 263.01 (+42.90)

Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target
at The Street - Wed Dec 31, 10:44AM CST
Shares of Cytokinetics (CYTK) were up in late morning trading Wednesday after Roth Capital increased its price target on the biotech company to $18 from $13.
CYTK: 8.01 (+1.11)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 8:15AM CST

CYTK: 8.01 (+1.11), NEON: 3.38 (+0.30), ARWR: 7.38 (-0.19), NRX: 13.35 (+8.70), PEIX: 10.33 (-0.38), BCLI: 4.76 (+0.88), MIG: 8.46 (+1.33), NDRM: 14.04 (-4.10)

Cytokinetics Shares Up 63.3% Since SmarTrend's Buy Recommendation (CYTK)
Comtex SmarTrend(R) - Tue Dec 30, 9:41AM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 2 months, Cytokinetics has returned 63.33% as of today's recent price of $6.90.
CYTK: 8.01 (+1.11)

Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 4:20PM CST
Kite Pharma, Inc. (KITE) submitted an investigational new drug application to the FDA for KTE-C19 for refractory aggressive non-Hodgkin lymphoma.
CYTK: 8.01 (+1.11), KITE: 57.67 (+1.73), MDCO: 27.67 (+0.02), AMGN: 159.29 (-1.34)

Cytokinetics continues Astellas-stoked up move
Seeking Alpha - at Seeking Alpha - Mon Dec 29, 2:22PM CST

CYTK: 8.01 (+1.11)

Yamana Gold and Ocwen are big market movers
AP - Fri Dec 26, 3:24PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
CYTK: 8.01 (+1.11), TSLA: 222.41 (+0.18), SSO.TO: 5.83 (+0.10), ABX.TO: 12.52 (-0.08), YRI.TO: 4.69 (-0.02), ABX: 10.75 (-0.11), OCN: 15.10 (+0.38), SSRI: 5.01 (+0.07), AUY: 4.02 (-0.05)

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Dec 26, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. What should the Seeking Alpha community be reading and writing about? Please leave...
MGNX: 35.07 (+0.95), CYTK: 8.01 (+1.11), JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), ALNY: 97.00 (unch), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86), BMY: 59.03 (-0.36), ANIK: 40.74 (+0.58)

Strong On High Volume: Cytokinetics (CYTK)
at The Street - Fri Dec 26, 9:59AM CST
Trade-Ideas LLC identified Cytokinetics (CYTK) as a strong on high relative volume candidate
CYTK: 8.01 (+1.11)

Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 8:50AM CST
Will Cytokinetics (CYTK) Continue to Surge Higher?
CYTK: 8.01 (+1.11)

Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 4:10PM CST
Cytokinetics (CYTK) shares jumped after announcing an amendment to its collaboration with Astellas.
CYTK: 8.01 (+1.11), AMGN: 159.29 (-1.34), AFFX: 9.87 (-0.12)

Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 1:10PM CST
Myriad Genetics' (MYGN) BracAnalysis CDx has become the first and only FDA-approved test to be permitted for use with AstraZeneca's latest FDA-cleared ovarian cancer drug ??? LynParza.
CYTK: 8.01 (+1.11), MYGN: 34.06 (-0.77), AZN: 70.38 (-0.31), AFFX: 9.87 (-0.12)

Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:32AM CST
Cytokinetics, Incorporated (CYTK) was a big mover last session, as the company saw its shares rise more than 12% on the day.
CYTK: 8.01 (+1.11), AFFX: 9.87 (-0.12)

Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:30PM CST
During the reported quarter,Myriad Genetics (MYGN) experienced heightened physician demand for the myRisk test.
CYTK: 8.01 (+1.11), MYGN: 34.06 (-0.77), ANIP: 56.39 (+2.03), AFFX: 9.87 (-0.12)

Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:02PM CST
Walgreens reported an impressive first quarter fiscal 2015 with both the top and bottom line comfortably beating the Zacks Consensus Estimate.
CYTK: 8.01 (+1.11), ABC: 90.16 (-1.12), AFFX: 9.87 (-0.12), WAG: 76.05 (-0.49)

Uptrend Call Working As Cytokinetics Stock Rises 29.5% (CYTK)
Comtex SmarTrend(R) - Tue Dec 23, 9:34AM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 2 months, Cytokinetics has returned 29.47% as of today's recent price of $5.47.
CYTK: 8.01 (+1.11)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 8:18AM CST

CYTK: 8.01 (+1.11), JRJC: 5.32 (-0.24), RDN: 16.72 (-0.11), CHK: 19.57 (-0.07), VNDA: 14.32 (-0.19), DRL: 3.95 (-0.09), ARIA: 6.87 (+0.05), ICLD: 2.92 (-0.02), NQ: 3.91 (-0.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyliion Faces Legal Drama Over Securities Violations

Updated Category News Views 4

A Stock Tango Entangled in Legal Webs Ah, Hyliion Holdings Corp. (NYSE American: HYLN) finds itself in the legal crosshairs this time around. On October 20, 2026, DJS Law Group sounded the alarm, reminding investors that there’s a class action lawsuit hanging over Hyliion's head like a gray cloud over a picnic. Allegations of securities law violations are the game of...

Continue Reading
Arbor Scientia Snags Second Consecutive BASA Win

Updated Category News Views 11

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Continue Reading
PetroCal Drives Dual Mandate for Orlando Car Wash

Updated Category News Views 7

PetroCal's Double Play in the Real Estate Game When you've been in this game as long as I have, you learn to keep an eye on players who can juggle multiple roles. And that's exactly what PetroCal Associates has pulled off with the Tommy's Express Car Wash project in Orlando. This isn't just another carwash setup, folks. We're talking about integrating into Unicorp...

Continue Reading
Chemours Faces Heat: 18.63% Stock Drop Jolts Investors

Updated Category News Views 3

Investors Rattled by Chemours' Stark Drop One moment, you're cruising along with the market, and the next, news hits like a brick. That’s what investors in The Chemours Company (NYSE: CC) faced when shares nosedived 18.63% after some unsettling revelations. Let's peel back the layers and see what's got everyone in a tizzy. What's Behind the Lawsuit? Securities lawsuits...

Continue Reading
iLAB Network Fuels Next-Gen Tech Startups with Innovation

Updated Category News Views 6

Igniting Innovation: 2150's New iLAB Network Here's the skinny on what's cookin' at the 2150 Center for Innovation, Commercialization & Growth. They've bagged another cohort for their iLAB network, and they’re laying the groundwork for the next wave of tech solutions that could shake things up across industries. Fresh Collaborations and Technological Foci Essentially,...

Continue Reading
Ashford Hospitality Trust: Fee Waiver and Share Buyback

Updated Category News Views 3

Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...

Continue Reading
First New Vegas Strip Intersection in 60 Years Planned

Updated Category News Views 6

Change Is Coming to the Las Vegas Strip Las Vegas is about to shake things up in a way not seen for six long decades. Yep, they're breaking ground on a brand new intersection on the Strip! You heard me right—Russell Road and Las Vegas Boulevard are getting some fresh asphalt, thanks to the backing of State Senator Fabian Doñate and Assemblymember Cecelia González....

Continue Reading
AMTD IDEA Group: Expanding Its Global Reach

Updated Category News Views 3

AMTD IDEA's Expansive Global Footprint While the rest of the market whirls, AMTD IDEA Group (NYSE: AMTD) is steadying itself with a comprehensive expansion that, quite frankly, demands a second look. Between weaving global media threads and dipping their toes into every alluring venture space, they've formed a tapestry not many could replicate. With facilities stretching...

Continue Reading
Shadeform's Spot: Monetizing Idle GPU Resources

Updated Category News Views 4

Shadeform's Spot Aims To Cut GPU Waste Imagine letting money burn while your GPUs sit in idle mode. That's the reality for many in the cloud computing sector, and Shadeform looks ready to tackle this inefficiency head-on. The launch of Spot, by the GPU Cloud Marketplace Shadeform, offers a novel way to make sure every floating gigaflop translates into some form of...

Continue Reading
Lawsuit Filed for Unfair ODP Acquisition Price

Updated Category News Views 2

Is ODP Getting a Raw Deal? Grab a cup of joe, because this is one of those sticky situations where the stakes are high, and the details are grimmer than last week's sales report. On August 19, 2026, Monteverde & Associates PC filed a lawsuit targeting the acquisition of The ODP Corporation by Atlas Holdings LLC, claiming the buyout price wasn't just low—it was roaringly...

Continue Reading

Top 5 Most Recently Viewed Articles

Raymond James Boosts Disc Medicine Stock to Strong Buy Rating

Updated Category News Views 39

Raymond James Signals Confidence in Disc Medicine In a recent analysis, Raymond James has upgraded the shares of Disc Medicine (NASDAQ:IRON) from an Outperform rating to a Strong Buy. This shift comes amidst growing optimism regarding the biopharmaceutical company’s prospects, particularly following their progress in drug development. Price Target Adjustment Along with...

Continue Reading
Sobi Showcases New Data at EHA 2026 in Stockholm

Updated Category News Views 7

Sobi Takes Center Stage at EHA 2026 They might call it business as usual, but for those in the hemophilia space, it's anything but that. Sobi, a biotech outfit nestled in the heart of Stockholm, is gearing up to dish out some fresh data at the European Hematology Association's 2026 Congress, right in their backyard. As the congress kicks off from June 11 through 14, you...

Continue Reading
Trump's Tariff Threats Impact U.S. Stock Futures and Markets

Updated Category News Views 166

Market Reaction to Tariff Threats U.S. stock index futures experienced a downturn after President-elect Donald Trump threatened to impose increased import tariffs, impacting investor sentiment. The implications of his remarks on tariffs covering countries like China and Canada have introduced a wave of concern among market participants. S&P 500 Futures dipped by 0.3%,...

Continue Reading
Zeni Unveils Innovative AI-Driven Treasury Management System

Updated Category News Views 107

Zeni Unveils Innovative AI-Driven Treasury Management Solution Zeni, the premier AI-powered bookkeeping platform tailored for startups and growing enterprises, has recently introduced a groundbreaking solution called Zeni Treasury. This new cash management offering is specifically designed to help businesses effectively manage their idle capital, ensuring they maintain...

Continue Reading
Car Nation Launches Exciting New Range of Used Cars

Updated Category News Views 283

Car Nation Expands Its Used Car Offerings Car Nation, a leading name in the used car market, is excited to introduce a brand-new selection of used vehicles at its dealership. Whether you're a family in search of a dependable car or an enthusiast looking for a high-performance sports model, Car Nation has something for everyone. A Wide Range of Quality Used Cars The latest...

Continue Reading